Boo! Time for my Halloween-themed roundup of Drug Channels news stories. In this issue:
- Scary! The gross-to-net bubble for insulin
- Shocking! Reality check on Medicare Part D rebates
- Spooky! Five things to Know About the EpiPen Settlement
Plus: Got a spare $22.5 million? Great! Then you can snag McKesson CEO John Hammergren’s secure eight-acre, 23,000-square-foot compound. Savor the video below and get ready to bid on November 15.
P.S. Watch out, Kim Kardashian! @DrugChannels now has nearly 3,100 followers on Twitter. You can follow along for daily tweets on cool studies and news that you might have missed.
Read more »
Source: Post feed
